{
    "title": "Eli Lilly stops development of lupus drug; XTL shares soar",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2778254/Eli-Lilly-stops-development-lupus-drug-XTL-shares-soar.html",
    "date": "2014-10-02",
    "keywords": [
        "drug",
        "lupus",
        "development",
        "percent",
        "october",
        "inc",
        "treatment",
        "disease",
        "tabalumab",
        "decision",
        "gmt",
        "email",
        "oct",
        "co",
        "disorder",
        "latestage",
        "trialswhile",
        "news",
        "adrs",
        "afternoon",
        "tradinglupus",
        "condition",
        "bodys",
        "immune",
        "system",
        "inflammation",
        "pain",
        "control",
        "preventionthe",
        "food",
        "administration",
        "benlysta",
        "march",
        "goal",
        "data",
        "efficacy",
        "context",
        "company",
        "nothing",
        "safety",
        "concernsthe",
        "charge",
        "share",
        "quarter",
        "foundation",
        "america",
        "evidence",
        "lillys",
        "pathway",
        "organization",
        "statementb",
        "blood",
        "component",
        "autoimmune",
        "diseasextl",
        "month",
        "midstage",
        "mid",
        "end",
        "year",
        "trial",
        "anthera",
        "york",
        "stock",
        "exchange",
        "reporting",
        "vidya",
        "l",
        "nathan",
        "bangalore",
        "editing",
        "kirti",
        "pandey"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}